| UHC Medicaid Medical & Drug | Orencia® (Abatacept) Injection for Intravenous Infusion – Community Plan Medical Benefit Drug Policy | 2026-06-01 |
| UHC Medicaid Medical & Drug | Orthognathic (Jaw) Surgery – Community Plan Medical Policy | 2026-06-01 |
| UHC Medicaid Medical & Drug | Oxlumo® (Lumasiran) and Rivfloza® (Nedosiran) – Community Plan Medical Benefit Drug Policy | 2026-06-01 |
| UHC Medicaid Medical & Drug | Radiation Therapy: Fractionation, Image-Guidance, and Special Services – Community Plan Medical Policy | 2026-06-01 |
| UHC Medicaid Medical & Drug | Repository Corticotropin Injections – Community Plan Medical Benefit Drug Policy | 2026-06-01 |
| UHC Medicaid Medical & Drug | RNA-Targeted Therapies (Amvuttra® and Onpattro®) – Community Plan Medical Benefit Drug Policy | 2026-06-01 |
| UHC Medicaid Medical & Drug | Spevigo® (Spesolimab-Sbzo) – Community Plan Medical Benefit Drug Policy | 2026-06-01 |
| UHC Medicaid Medical & Drug | Surgery of the Knee – Community Plan Medical Policy | 2026-06-01 |
| UHC Medicaid Medical & Drug | Treatment of Temporomandibular Joint Disorders – Community Plan Medical Policy | 2026-06-01 |
| UHC Medicaid Medical & Drug | Trogarzo® (Ibalizumab-Uiyk) – Community Plan Medical Benefit Drug Policy | 2026-06-01 |